Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Nov 19, 2026
TickeronGET DAILY SIGNALS
Why Is Magnera Corporation (MAGN) Stock Up 7.98% Today?

Why Is Magnera Corporation (MAGN) Stock Up 7.98% Today?

Key Takeaways

  • MAGN shares rose 7.98% to $12.86, extending a post-earnings advance from the prior close of $11.91.
  • The primary catalyst was the fiscal fourth-quarter and full-year 2026 report, which showed record quarterly operating cash flow and free cash flow above the high end of the company's own guidance.
  • Secondary drivers: $122 million of debt reduction in fiscal 2026, about $600 million of total liquidity, and fiscal 2027 adjusted EBITDA guidance of $390 million to $410 million.
  • A revenue miss ($851 million against roughly $899 million expected) and a $106 million non-cash impairment tempered the gain rather than reversing it.
  • Broader context: the materials sector was weaker, with the sector benchmark and major packaging peers trading lower, so the move was company-specific rather than sector-driven.
  • News Significance Score: 52/100 — Moderate earnings and guidance news amplified by a move roughly four times the stock's typical daily swing.
  • Traders are watching whether the cash-flow story holds through fiscal 2027 and whether leverage continues to fall toward management's roughly 3x target.
  • For deeper detail on MAGN, explore the Price Targets, Earnings, and Forecast pages.
  • Readers can also review Trending AI Robots to see which automated strategies are performing best in the current market.

Opening Summary

Magnera Corporation (MAGN) is a Charlotte, North Carolina-based maker of nonwoven and specialty materials used in wipes, personal care, healthcare garments, filtration, food packaging and infrastructure applications. The stock traded at $12.86 in Thursday's session, up $0.95, or 7.98%, from Wednesday's close of $11.91. The direction was firmly higher, with the move following the release of fiscal fourth-quarter and full-year 2026 results after Wednesday's close. Investors focused on cash generation and deleveraging rather than a soft top line.

Record Cash Flow and Debt Reduction Drive the Rally

The quarter, which ended September 26, delivered net sales of $851 million, up 1.4% year over year, and adjusted EBITDA of $97 million versus $90 million a year earlier — an 8% improvement. The headline number for the market, though, was cash: operating cash flow hit a quarterly record of $99 million, and $57 million of debt was repaid in the period.

For the full fiscal year, Magnera generated $115 million of free cash flow, finishing above the upper end of its original guidance range, on sales of $3.30 billion and adjusted EBITDA of $378 million. Borrowings fell by $122 million to roughly $1.85 billion, with about $294 million of cash and approximately $600 million of available liquidity at year end. Against an equity market value of roughly $426 million at Wednesday's close, that free cash flow equates to a yield well above 25% — a valuation argument that clearly resonated with buyers.

Fiscal 2027 Guidance Points to Further EBITDA Growth

Management guided fiscal 2027 adjusted EBITDA to $390 million to $410 million, a midpoint implying roughly 6% growth at constant currency, driven by synergy realization, its Project CORE operating initiatives and an improved product mix. Operating cash flow is projected at $195 million to $215 million, with capital spending near $85 million and free cash flow of $110 million to $130 million. The company said all free cash flow will go toward debt reduction, with leverage expected near 3.6x at the midpoint before further repayments and a roughly 3x target ahead. That plan gives the earnings-driven move a forward-looking anchor rather than a one-quarter bounce.

Revenue Miss and $106 Million Impairment Cap the Upside

The report was not clean. Sales of $851 million landed about $48 million below the year-ago comparison's implied consensus near $899 million, and underlying volumes contracted 4%, with the Americas down 2% and overseas markets down 6%. Pricing added $43 million, largely pass-through of higher raw material costs. A $106 million goodwill and other impairment — $65 million in the Americas and $41 million internationally — pushed the quarter to a $90 million operating loss and a net loss of $141 million, versus a $40 million loss a year earlier.

Those items explain why the stock is not holding its best after-hours print. Shares jumped as much as 11.6% to $13.29 in Wednesday's extended session, then moderated toward $12.86 during regular trading, leaving the rally intact but trimmed.

Market Context and Trading Activity

The advance ran against a softer tape. The materials sector benchmark (XLB) was down about 1.4%, packaging peer AMCR fell roughly 2.8%, SON lost about 2.5% and AVNT slipped 1.2%, confirming the gain as a company-specific reaction rather than sector sympathy.

Turnover remains thin: average daily volume over the past three months runs near 370,000 shares on a float of roughly 30 million shares, a structure that magnifies percentage moves. Technically, the stock had slipped about 10% from $13.23 on November 11 to $11.91 before the report, so part of the session's strength reflects a rebound off that pullback; shares remain below the mid-November highs near $13.30. The 52-week range is $7.82 to $15.52.

News Significance Score

The scale runs from 0, meaning no meaningful news and a move that is normal for the stock, to 100, meaning transformative news and an extreme, rare price move. Magnera scores 52 out of 100.

Verified news strength was moderate: a quarterly revenue miss and a large impairment were offset by free cash flow above guidance and a credible fiscal 2027 EBITDA outlook, material relative to a company of this size but not transformative. The price move was unusual — about 4.2 times the stock's typical daily swing of roughly 1.9%, and larger than any single session in the past 60 trading days, where the biggest move was about 6.6%. Moderate news plus a rare move produces the mid-range score.

What Comes Next for MAGN

With fiscal 2026 closed, attention shifts to fiscal 2027 execution. Investors will watch whether underlying volumes stabilize after the 4% decline, particularly in Europe and China, and whether pricing holds as raw material and energy costs evolve; management has hedged roughly 70% of its European energy exposure for the year. Quarterly cash flow delivery against the $110 million to $130 million free cash flow target, and the pace of debt repayment toward the 3x leverage goal, are the key scorecards. Analyst coverage remains thin, with a Hold-leaning consensus and a wide spread of targets, so estimate revisions could move the stock disproportionately. Risks include continued demand weakness in hygiene and wipes, currency swings, restructuring charges and the possibility of further non-cash writedowns.

Trending AI Robots

Tickeron maintains hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions earn a place in the curated Trending AI Robots section. The listed bots vary by strategy, timeframe, performance metrics and the symbols they trade, so the lineup rotates as conditions change. Reviewing that page is a practical way to see which automated approaches are working right now and how they compare before deciding what fits your own process.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MAGN

Contributor

Dem Sem's AvatarDem Sem|Expert

MAGN's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Oscillator for MAGN moved out of overbought territory on November 12, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 instances where the indicator moved out of the overbought zone. In 16 of the 17 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for MAGN turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 39 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MAGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

MAGN broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on November 19, 2026. You may want to consider a long position or call options on MAGN as a result. In 58 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.

MAGN moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MAGN crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.

The 50-day moving average for MAGN moved above the 200-day moving average on November 19, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +1.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where MAGN advanced for three days, in 186 of 264 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

The Aroon Indicator entered an Uptrend today. In 65 of 88 cases where MAGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.388) is normal, around the industry mean (21.731). P/E Ratio (-0.646) is within average values for comparable stocks, (16.288). Projected Growth (PEG Ratio) (0.120) is also within normal values, averaging (1.518). Dividend Yield (0.074) settles around the average of (0.032) among similar stocks. P/S Ratio (0.129) is also within normal values, averaging (1.902).

The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. MAGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MAGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

Notable companies

The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).

Industry description

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

Market Cap

The average market capitalization across the Household/Personal Care Industry is 25.17B. The market cap for tickers in the group ranges from 60.48K to 384.17B. PG holds the highest valuation in this group at 384.17B. The lowest valued company is EOSS at 60.48K.

High and low price notable news

The average weekly price growth across all stocks in the Household/Personal Care Industry was -5%. For the same Industry, the average monthly price growth was 11%, and the average quarterly price growth was 19%. SLSN experienced the highest price growth at 63%, while BYAH experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Household/Personal Care Industry was 6%. For the same stocks of the Industry, the average monthly volume growth was -14% and the average quarterly volume growth was 75%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 50
Price Growth Rating: 46
SMR Rating: 73
Profit Risk Rating: 86
Seasonality Score: 32 (-100 ... +100)
Paper Trades 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of papers and fiber-based engineered materials

Industry HouseholdPersonalCare

Industry
Pulp And Paper
Address
9335 Harris Corners parkway
Phone
+1 866 744-7380
Employees
8500
Web
https://www.magnera.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
ROM is an established, leveraged exchange-traded fund (ETF) that targets twice (2x) the daily return of the S&P Technology Select Sector Index, while XXX is a recently launched blended ETF pairing large-cap U.S. equities with XRP exposure. ROM benefits from deep liquidity and roughly $1.1 billion in AUM (assets under management); XXX remains far smaller, with assets measured in the hundreds of thousands of dollars.
NVIDIA (NVDA) has declined roughly 32.6% over the last 30 days, falling from $216.47 on October 20 to around $146 in mid-November trading. The selloff was triggered by the surprise resignation of founder and CEO Jensen Huang, along with governance, regulatory, and China-related concerns.